Horm Metab Res 2024; 56(01): 8-9
DOI: 10.1055/a-2213-9266
Editorial

The Adrenal Gland: A Fascinating Object of Research and Clinical Care Showcased at the 15th German Adrenal Conference in Dresden

Matthias Kroiss
1   Dept. of Internal Medicine IV, LMU, Muenchen, Germany
,
Nicole Bechmann
2   Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany
› Author Affiliations
Funding Information German Research Foundation (DFG), collaborative research center 205 "The adrenal: central relay in health and disease" (project number 314061271).

Dear colleagues,

When younger fellows ask for guidance on how to choose a research project, many aspects require consideration: how to select a supervisor and mentor, should one change the institution, how does the project boost the later professional career, what are personal and professional aims. As many can probably relate it is passion for the research topic, both by the fellow and the mentor, that will go a long way and most often result in successful project completion.



Publication History

Article published online:
03 January 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Kienitz T, Bechmann N, Deutschbein T. et al. Adrenal crisis – definition, prevention and treatment: results from a Delphi survey. Horm Metab Res 2024; 56: 10-15
  • 2 Wäscher H, Knauerhase A, Klar B. et al. On primary adrenal insufficiency with normal concentrations of cortisol – early manifestation of Addison’s disease. Horm Metab Res 2024; 56: 16-19
  • 3 Chifu I, Quinkler M, Altieri B. et al. Morbidity in patients with chronic adrenal insufficiency – cardiovascular risk factors and hospitalization rate compared to population based controls. Horm Metab Res 2024; 56: 20-29
  • 4 Weniger M, Mattes M, Grünewald TG. et al. Quantitative characterization of ectopic adrenal gene expression in fetal testes in 21-hydroxylase deficient mice. Horm Metab Res 2024; 56: 38-44
  • 5 Kiewert C, Jedanowski J, Hauffa BP. et al. Transition from paediatric to adult care in CAH: 20 years of experience at a tertiary referral center. Horm Metab Res 2024; 56: 45-50
  • 6 Karma B, Pellegata NS, Mohr H. Animal and cell culture models of PPGLs – achievements and limitations. Horm Metab Res 2024; 56: 51-64
  • 7 Kimpel O, Dischinger U, Altieri B. et al. Current evidence on local therapies in advanced adrenocortical carcinoma. Horm Metab Res 2024; 56: 91-98
  • 8 Schwarzlmueller P, Corradini S, Seidensticker M. et al. High-dose rate brachytherapy combined with PD-1 blockade as a treatment for metastatic adrenocortical carcinoma – a single center case series. Horm Metab Res 2024; 56: 30-37
  • 9 Coszma D, Siatra P, Bornstein SR. et al. Sensitivity of the neuroendocrine stress axis in metabolic diseases. Horm Metab Res 2024; 56: 65-77
  • 10 Pötzl B, Kürzinger L, Stopper H. et al. Endocrine disruptors: focus on the adrenal cortex. Horm Metab Res 2024; 56: 78-90
  • 11 Chen L, Adolf C, Reincke M. et al. Salt and aldosterone – reciprocal and combined effects in preclinical models and humans. Horm Metab Res 2024; 56: 99-106